(Q51177826)

31 March 2018

title

A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units (English)

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

9 July 2024

3

J-P Gangneux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825438

9 July 2024

author name string

J-P Mira

2

1 reference

31 March 2018

AmarCand study group

6

1 reference

31 March 2018

P. Montravers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825438

9 July 2024

O. Leroy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825438

9 July 2024

O. Lortholary

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825438

9 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20825438

9 July 2024

publication date

19 October 2010

1 reference

31 March 2018

full work available at URL

http://www.clinicalmicrobiologyandinfection.com/article/S1198743X14613902/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20825438

https://api.elsevier.com/content/article/PII:S1198743X14613902?httpAccept=text/xml

9 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

https://api.elsevier.com/content/article/PII:S1198743X14613902?httpAccept=text/plain

9 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Clinical Microbiology and Infection

9 July 2024

published in

1 reference

31 March 2018

volume

17

1 reference

31 March 2018

issue

7

1 reference

31 March 2018

page(s)

1061-1067

1 reference

31 March 2018

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

9 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Impact of enteral versus parenteral nutrition on the incidence of fungal infections: a retrospective study in ICU patients on mechanical ventilation with selective digestive decontamination

9 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Candida colonization and subsequent infections in critically ill surgical patients

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?

9 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis

9 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).

9 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Abdominal candidiasis in surgical patients

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations

9 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Candida as a risk factor for mortality in peritonitis

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

9 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

9 July 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Comparison of caspofungin and amphotericin B for invasive candidiasis

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

9 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

9 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

9 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

9 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Clinical significance of Candida isolated from peritoneum in surgical patients

9 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group

9 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

Anidulafungin versus fluconazole for invasive candidiasis

9 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1469-0691.2010.03360.X

9 July 2024

Identifiers

1 reference

31 March 2018

1 reference

31 March 2018